ZW800-PEG: A Renal Clearable Zwitterionic Near-Infrared Fluorophore for Potential Clinical Translation.


Journal

Angewandte Chemie (International ed. in English)
ISSN: 1521-3773
Titre abrégé: Angew Chem Int Ed Engl
Pays: Germany
ID NLM: 0370543

Informations de publication

Date de publication:
14 06 2021
Historique:
revised: 30 03 2021
received: 21 02 2021
pubmed: 16 4 2021
medline: 1 9 2021
entrez: 15 4 2021
Statut: ppublish

Résumé

Near-infrared (NIR) fluorescence imaging has advanced medical imaging and image-guided interventions during the past three decades. Despite tremendous advances in imaging devices, surprisingly only a few dyes are currently available in the clinic. Previous fluorophores, ZW800-1A and ZW800-1C, significantly improved the poor performance of the FDA-approved indocyanine green. However, ZW800-1A is not stable in serum and ZW800-1C induces severe stacking in aqueous media. To solve such dilemmas, ZW800-PEG was designed by introducing a flexible yet stable thiol PEG linker. ZW800-PEG shows high solubility in both aqueous and organic solvents, thus improving renal clearance with minimal binding to serum proteins during systemic circulation. The sulfide group on the meso position of the heptamethine core improves serum stability and physicochemical properties including the maximum emission wavelength shift to 800 nm, enabling the use of ZW800-PEG for image-guided interventions and augmenting photothermal therapy.

Identifiants

pubmed: 33857346
doi: 10.1002/anie.202102640
pmc: PMC8428668
mid: NIHMS1737746
doi:

Substances chimiques

Fluorescent Dyes 0
Polyethylene Glycols 3WJQ0SDW1A

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13847-13852

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL143020
Pays : United States
Organisme : NIH HHS
ID : R01EB022230
Pays : United States
Organisme : National Research Foundation of Korea
ID : 2019M3D1A1078938
Organisme : NIBIB NIH HHS
ID : R01 EB022230
Pays : United States
Organisme : NIH HHS
ID : R01HL143020
Pays : United States

Informations de copyright

© 2021 Wiley-VCH GmbH.

Références

Nat Biomed Eng. 2020 Mar;4(3):245-246
pubmed: 32165731
Chem Commun (Camb). 2017 Feb 4;53(10):1611-1614
pubmed: 28085163
Chem Commun (Camb). 2015 Mar 7;51(19):3989-92
pubmed: 25664357
Contrast Media Mol Imaging. 2012 Nov-Dec;7(6):516-24
pubmed: 22991318
Sci Rep. 2017 Oct 24;7(1):13958
pubmed: 29066756
Mol Imaging. 2010 Oct;9(5):237-55
pubmed: 20868625
Biomacromolecules. 2015 Sep 14;16(9):3054-61
pubmed: 26258264
Nat Biomed Eng. 2020 Mar;4(3):259-271
pubmed: 31873212
Theranostics. 2015 Mar 01;5(6):609-17
pubmed: 25825600
Biomed Mater. 2013 Feb;8(1):014110
pubmed: 23353894
Chem Commun (Camb). 2010 Oct 21;46(39):7406-8
pubmed: 20830356
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015 Nov-Dec;7(6):828-38
pubmed: 25645081
Angew Chem Int Ed Engl. 2011 Jul 4;50(28):6258-63
pubmed: 21656624
Quant Imaging Med Surg. 2019 Sep;9(9):1548-1555
pubmed: 31667140
Korean J Thorac Cardiovasc Surg. 2019 Aug;52(4):205-220
pubmed: 31403028
Acc Chem Res. 2016 Sep 20;49(9):1731-40
pubmed: 27564418
Chem Asian J. 2011 Jun 6;6(6):1353-7
pubmed: 21509942
Mol Imaging Biol. 2016 Feb;18(1):52-61
pubmed: 26084246
Angew Chem Int Ed Engl. 2010 Dec 17;49(51):9816-8
pubmed: 21089086
Tissue Eng Regen Med. 2019 Sep 24;16(5):433-442
pubmed: 31624699
Nat Nanotechnol. 2010 Jan;5(1):42-7
pubmed: 19893516
Chem Commun (Camb). 2020 Jan 14;56(4):523-526
pubmed: 31821402
Nat Commun. 2019 Mar 5;10(1):1058
pubmed: 30837470
Nat Biotechnol. 2013 Feb;31(2):148-53
pubmed: 23292608
J Med Chem. 2015 Mar 26;58(6):2845-54
pubmed: 25711712
Curr Drug Metab. 2008 Nov;9(9):854-9
pubmed: 18991581
J Biomed Opt. 2016 Aug 1;21(8):80901
pubmed: 27533438
Chem Commun (Camb). 2020 Apr 14;56(30):4180-4183
pubmed: 32167112
RSC Adv. 2014 Jan 1;4(102):58762-58768
pubmed: 25530846
Chem Eng J. 2018 May 15;340:51-57
pubmed: 29962899
Biomaterials. 2012 Jun;33(17):4370-8
pubmed: 22425023
J Org Chem. 2006 Sep 29;71(20):7862-5
pubmed: 16995699

Auteurs

Chengeng Yang (C)

Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02129, USA.

Haoran Wang (H)

Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02129, USA.
Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, P. R. China.

Shinya Yokomizo (S)

Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02129, USA.

Morgan Hickey (M)

Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02129, USA.

Hyejin Chang (H)

Division of Science Education, Kangwon National University, Chuncheon, 24341, S. Korea.

Homan Kang (H)

Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02129, USA.

Takeshi Fukuda (T)

Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02129, USA.

Mi Young Song (MY)

BioActs Co., Ltd., Incheon, 21666, S. Korea.

Sang Yeul Lee (SY)

BioActs Co., Ltd., Incheon, 21666, S. Korea.

Jin Woo Park (JW)

BioActs Co., Ltd., Incheon, 21666, S. Korea.

Kai Bao (K)

Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02129, USA.

Hak Soo Choi (HS)

Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02129, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH